0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Delivery Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15C6117
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Delivery Drugs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Targeted Delivery Drugs Market Research Report 2025

Code: QYRE-Auto-15C6117
Report
September 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted Delivery Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Targeted Delivery Drugs Market

Targeted Delivery Drugs Market

The global market for Targeted Delivery Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Targeted delivery of drugs is defined as a method of injecting drugs into the body so that they only target specific parts of the body. Targeted delivery of drugs is designed to target, extend and protect interactions with diseased tissues.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Targeted Delivery Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Delivery Drugs.
The Targeted Delivery Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Targeted Delivery Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted Delivery Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Targeted Delivery Drugs Market Report

Report Metric Details
Report Name Targeted Delivery Drugs Market
CAGR 5%
Segment by Type
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Drug Eluting Stents
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Adverum, Arrowhead Pharmaceuticals, Bayer, Windtree Therapeutics, Immunocore, Mankind Pharma, Roche, Ra Pharma, Keystone Nano, Lipocine, MultiVir
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Targeted Delivery Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Delivery Drugs Market report?

Ans: The main players in the Targeted Delivery Drugs Market are Adverum, Arrowhead Pharmaceuticals, Bayer, Windtree Therapeutics, Immunocore, Mankind Pharma, Roche, Ra Pharma, Keystone Nano, Lipocine, MultiVir

What are the Application segmentation covered in the Targeted Delivery Drugs Market report?

Ans: The Applications covered in the Targeted Delivery Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Targeted Delivery Drugs Market report?

Ans: The Types covered in the Targeted Delivery Drugs Market report are Ocular Drug Delivery, Pulmonary Drug Delivery, Drug Eluting Stents, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted Delivery Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ocular Drug Delivery
1.2.3 Pulmonary Drug Delivery
1.2.4 Drug Eluting Stents
1.2.5 Other
1.3 Market by Application
1.3.1 Global Targeted Delivery Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted Delivery Drugs Market Perspective (2020-2031)
2.2 Global Targeted Delivery Drugs Growth Trends by Region
2.2.1 Global Targeted Delivery Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Targeted Delivery Drugs Historic Market Size by Region (2020-2025)
2.2.3 Targeted Delivery Drugs Forecasted Market Size by Region (2026-2031)
2.3 Targeted Delivery Drugs Market Dynamics
2.3.1 Targeted Delivery Drugs Industry Trends
2.3.2 Targeted Delivery Drugs Market Drivers
2.3.3 Targeted Delivery Drugs Market Challenges
2.3.4 Targeted Delivery Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted Delivery Drugs Players by Revenue
3.1.1 Global Top Targeted Delivery Drugs Players by Revenue (2020-2025)
3.1.2 Global Targeted Delivery Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Targeted Delivery Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Targeted Delivery Drugs Revenue
3.4 Global Targeted Delivery Drugs Market Concentration Ratio
3.4.1 Global Targeted Delivery Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted Delivery Drugs Revenue in 2024
3.5 Global Key Players of Targeted Delivery Drugs Head office and Area Served
3.6 Global Key Players of Targeted Delivery Drugs, Product and Application
3.7 Global Key Players of Targeted Delivery Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted Delivery Drugs Breakdown Data by Type
4.1 Global Targeted Delivery Drugs Historic Market Size by Type (2020-2025)
4.2 Global Targeted Delivery Drugs Forecasted Market Size by Type (2026-2031)
5 Targeted Delivery Drugs Breakdown Data by Application
5.1 Global Targeted Delivery Drugs Historic Market Size by Application (2020-2025)
5.2 Global Targeted Delivery Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Targeted Delivery Drugs Market Size (2020-2031)
6.2 North America Targeted Delivery Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Targeted Delivery Drugs Market Size by Country (2020-2025)
6.4 North America Targeted Delivery Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted Delivery Drugs Market Size (2020-2031)
7.2 Europe Targeted Delivery Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Targeted Delivery Drugs Market Size by Country (2020-2025)
7.4 Europe Targeted Delivery Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted Delivery Drugs Market Size (2020-2031)
8.2 Asia-Pacific Targeted Delivery Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Targeted Delivery Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Targeted Delivery Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted Delivery Drugs Market Size (2020-2031)
9.2 Latin America Targeted Delivery Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Targeted Delivery Drugs Market Size by Country (2020-2025)
9.4 Latin America Targeted Delivery Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted Delivery Drugs Market Size (2020-2031)
10.2 Middle East & Africa Targeted Delivery Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Targeted Delivery Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Targeted Delivery Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adverum
11.1.1 Adverum Company Details
11.1.2 Adverum Business Overview
11.1.3 Adverum Targeted Delivery Drugs Introduction
11.1.4 Adverum Revenue in Targeted Delivery Drugs Business (2020-2025)
11.1.5 Adverum Recent Development
11.2 Arrowhead Pharmaceuticals
11.2.1 Arrowhead Pharmaceuticals Company Details
11.2.2 Arrowhead Pharmaceuticals Business Overview
11.2.3 Arrowhead Pharmaceuticals Targeted Delivery Drugs Introduction
11.2.4 Arrowhead Pharmaceuticals Revenue in Targeted Delivery Drugs Business (2020-2025)
11.2.5 Arrowhead Pharmaceuticals Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Targeted Delivery Drugs Introduction
11.3.4 Bayer Revenue in Targeted Delivery Drugs Business (2020-2025)
11.3.5 Bayer Recent Development
11.4 Windtree Therapeutics
11.4.1 Windtree Therapeutics Company Details
11.4.2 Windtree Therapeutics Business Overview
11.4.3 Windtree Therapeutics Targeted Delivery Drugs Introduction
11.4.4 Windtree Therapeutics Revenue in Targeted Delivery Drugs Business (2020-2025)
11.4.5 Windtree Therapeutics Recent Development
11.5 Immunocore
11.5.1 Immunocore Company Details
11.5.2 Immunocore Business Overview
11.5.3 Immunocore Targeted Delivery Drugs Introduction
11.5.4 Immunocore Revenue in Targeted Delivery Drugs Business (2020-2025)
11.5.5 Immunocore Recent Development
11.6 Mankind Pharma
11.6.1 Mankind Pharma Company Details
11.6.2 Mankind Pharma Business Overview
11.6.3 Mankind Pharma Targeted Delivery Drugs Introduction
11.6.4 Mankind Pharma Revenue in Targeted Delivery Drugs Business (2020-2025)
11.6.5 Mankind Pharma Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Targeted Delivery Drugs Introduction
11.7.4 Roche Revenue in Targeted Delivery Drugs Business (2020-2025)
11.7.5 Roche Recent Development
11.8 Ra Pharma
11.8.1 Ra Pharma Company Details
11.8.2 Ra Pharma Business Overview
11.8.3 Ra Pharma Targeted Delivery Drugs Introduction
11.8.4 Ra Pharma Revenue in Targeted Delivery Drugs Business (2020-2025)
11.8.5 Ra Pharma Recent Development
11.9 Keystone Nano
11.9.1 Keystone Nano Company Details
11.9.2 Keystone Nano Business Overview
11.9.3 Keystone Nano Targeted Delivery Drugs Introduction
11.9.4 Keystone Nano Revenue in Targeted Delivery Drugs Business (2020-2025)
11.9.5 Keystone Nano Recent Development
11.10 Lipocine
11.10.1 Lipocine Company Details
11.10.2 Lipocine Business Overview
11.10.3 Lipocine Targeted Delivery Drugs Introduction
11.10.4 Lipocine Revenue in Targeted Delivery Drugs Business (2020-2025)
11.10.5 Lipocine Recent Development
11.11 MultiVir
11.11.1 MultiVir Company Details
11.11.2 MultiVir Business Overview
11.11.3 MultiVir Targeted Delivery Drugs Introduction
11.11.4 MultiVir Revenue in Targeted Delivery Drugs Business (2020-2025)
11.11.5 MultiVir Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Targeted Delivery Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Ocular Drug Delivery
 Table 3. Key Players of Pulmonary Drug Delivery
 Table 4. Key Players of Drug Eluting Stents
 Table 5. Key Players of Other
 Table 6. Global Targeted Delivery Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Targeted Delivery Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Targeted Delivery Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Targeted Delivery Drugs Market Share by Region (2020-2025)
 Table 10. Global Targeted Delivery Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Targeted Delivery Drugs Market Share by Region (2026-2031)
 Table 12. Targeted Delivery Drugs Market Trends
 Table 13. Targeted Delivery Drugs Market Drivers
 Table 14. Targeted Delivery Drugs Market Challenges
 Table 15. Targeted Delivery Drugs Market Restraints
 Table 16. Global Targeted Delivery Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Targeted Delivery Drugs Market Share by Players (2020-2025)
 Table 18. Global Top Targeted Delivery Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Delivery Drugs as of 2024)
 Table 19. Ranking of Global Top Targeted Delivery Drugs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Targeted Delivery Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Targeted Delivery Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Targeted Delivery Drugs, Product and Application
 Table 23. Global Key Players of Targeted Delivery Drugs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Targeted Delivery Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Targeted Delivery Drugs Revenue Market Share by Type (2020-2025)
 Table 27. Global Targeted Delivery Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Targeted Delivery Drugs Revenue Market Share by Type (2026-2031)
 Table 29. Global Targeted Delivery Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Targeted Delivery Drugs Revenue Market Share by Application (2020-2025)
 Table 31. Global Targeted Delivery Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Targeted Delivery Drugs Revenue Market Share by Application (2026-2031)
 Table 33. North America Targeted Delivery Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Targeted Delivery Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Targeted Delivery Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Targeted Delivery Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Targeted Delivery Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Targeted Delivery Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Targeted Delivery Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Targeted Delivery Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Targeted Delivery Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Targeted Delivery Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Targeted Delivery Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Targeted Delivery Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Targeted Delivery Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Targeted Delivery Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Targeted Delivery Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Adverum Company Details
 Table 49. Adverum Business Overview
 Table 50. Adverum Targeted Delivery Drugs Product
 Table 51. Adverum Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 52. Adverum Recent Development
 Table 53. Arrowhead Pharmaceuticals Company Details
 Table 54. Arrowhead Pharmaceuticals Business Overview
 Table 55. Arrowhead Pharmaceuticals Targeted Delivery Drugs Product
 Table 56. Arrowhead Pharmaceuticals Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 57. Arrowhead Pharmaceuticals Recent Development
 Table 58. Bayer Company Details
 Table 59. Bayer Business Overview
 Table 60. Bayer Targeted Delivery Drugs Product
 Table 61. Bayer Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 62. Bayer Recent Development
 Table 63. Windtree Therapeutics Company Details
 Table 64. Windtree Therapeutics Business Overview
 Table 65. Windtree Therapeutics Targeted Delivery Drugs Product
 Table 66. Windtree Therapeutics Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 67. Windtree Therapeutics Recent Development
 Table 68. Immunocore Company Details
 Table 69. Immunocore Business Overview
 Table 70. Immunocore Targeted Delivery Drugs Product
 Table 71. Immunocore Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 72. Immunocore Recent Development
 Table 73. Mankind Pharma Company Details
 Table 74. Mankind Pharma Business Overview
 Table 75. Mankind Pharma Targeted Delivery Drugs Product
 Table 76. Mankind Pharma Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 77. Mankind Pharma Recent Development
 Table 78. Roche Company Details
 Table 79. Roche Business Overview
 Table 80. Roche Targeted Delivery Drugs Product
 Table 81. Roche Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 82. Roche Recent Development
 Table 83. Ra Pharma Company Details
 Table 84. Ra Pharma Business Overview
 Table 85. Ra Pharma Targeted Delivery Drugs Product
 Table 86. Ra Pharma Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 87. Ra Pharma Recent Development
 Table 88. Keystone Nano Company Details
 Table 89. Keystone Nano Business Overview
 Table 90. Keystone Nano Targeted Delivery Drugs Product
 Table 91. Keystone Nano Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 92. Keystone Nano Recent Development
 Table 93. Lipocine Company Details
 Table 94. Lipocine Business Overview
 Table 95. Lipocine Targeted Delivery Drugs Product
 Table 96. Lipocine Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 97. Lipocine Recent Development
 Table 98. MultiVir Company Details
 Table 99. MultiVir Business Overview
 Table 100. MultiVir Targeted Delivery Drugs Product
 Table 101. MultiVir Revenue in Targeted Delivery Drugs Business (2020-2025) & (US$ Million)
 Table 102. MultiVir Recent Development
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Targeted Delivery Drugs Picture
 Figure 2. Global Targeted Delivery Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Targeted Delivery Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Ocular Drug Delivery Features
 Figure 5. Pulmonary Drug Delivery Features
 Figure 6. Drug Eluting Stents Features
 Figure 7. Other Features
 Figure 8. Global Targeted Delivery Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Targeted Delivery Drugs Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Other Case Studies
 Figure 13. Targeted Delivery Drugs Report Years Considered
 Figure 14. Global Targeted Delivery Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Targeted Delivery Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Targeted Delivery Drugs Market Share by Region: 2024 VS 2031
 Figure 17. Global Targeted Delivery Drugs Market Share by Players in 2024
 Figure 18. Global Top Targeted Delivery Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Delivery Drugs as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Targeted Delivery Drugs Revenue in 2024
 Figure 20. North America Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Targeted Delivery Drugs Market Share by Country (2020-2031)
 Figure 22. United States Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Targeted Delivery Drugs Market Share by Country (2020-2031)
 Figure 26. Germany Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Targeted Delivery Drugs Market Share by Region (2020-2031)
 Figure 34. China Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Targeted Delivery Drugs Market Share by Country (2020-2031)
 Figure 42. Mexico Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Targeted Delivery Drugs Market Share by Country (2020-2031)
 Figure 46. Turkey Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Targeted Delivery Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Adverum Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 50. Arrowhead Pharmaceuticals Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 51. Bayer Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 52. Windtree Therapeutics Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 53. Immunocore Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 54. Mankind Pharma Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 55. Roche Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 56. Ra Pharma Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 57. Keystone Nano Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 58. Lipocine Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 59. MultiVir Revenue Growth Rate in Targeted Delivery Drugs Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS